This would suggest that β-catenin is transcriptionally regulated by STAT3 and is consistent with studies in breast cancer showing direct binding of STAT3 to the β-catenin promoter (Armanious et al. 2010). This evidence concerns the gene STAT3 and breast carcinoma.